Clinical Decision Making with Head and Neck Cancer Patients with Dysphagia.


Journal

Seminars in speech and language
ISSN: 1098-9056
Titre abrégé: Semin Speech Lang
Pays: United States
ID NLM: 8405117

Informations de publication

Date de publication:
06 2019
Historique:
entrez: 4 6 2019
pubmed: 4 6 2019
medline: 21 7 2020
Statut: ppublish

Résumé

Dysphagia is a common challenge faced by patients with head and neck cancer. Management of these patients is quite distinct from many other dysphagia etiologies due to the nature of surgical removal of organs critical to swallowing, the ability to provide preventative therapies, and the variable risk for complications related to dysphagia. Thus, clinicians providing care to the head and neck cancer population need to understand these differences when employing clinical decision making. In addition, changes in the demographics of head and neck cancer, related predominantly to the epidemic of oropharyngeal cancer associated with the human papillomavirus, have further transformed both the types of patients and the types of treatments offered. These epidemiologic factors further complicate the decision-making process for clinicians. This article provides a framework for decision making in the surgical and nonsurgical patient with head and neck cancer.

Identifiants

pubmed: 31158905
doi: 10.1055/s-0039-1688979
doi:

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

213-226

Informations de copyright

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Déclaration de conflit d'intérêts

Disclosure The authors report no conflicts of interest in this work.

Auteurs

Heather Starmer (H)

Department of Otolaryngology - Head and Neck Surgery, Stanford University, Palo Alto, California.
Head and Neck Speech and Swallowing Rehabilitation, Stanford Cancer Center, Palo Alto, California.

Jeffrey Edwards (J)

Clinical Speech-Language Pathologist, Stanford Cancer Center, Palo Alto, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH